Skip to main content

Understanding the impact of DNA demethylation in Motor Neuron Disorders

Project description

Insight into the epigenetic profile of motor neuron disorders

Motor neuron disorders (MND), comprising spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), are a group of devastating diseases mainly manifested by motor neuron degeneration. Emerging evidence suggests that disease severity is modulated through epigenetics in which DNA methylation plays a dominant role. The scope of the EU-funded MANTIS project is to uncover the epigenetic mechanism gone awry in MND. Leveraging cutting-edge techniques from next-generation sequencing to single-cell mass cytometry and patient-derived iPSCs, the scientists will explore the role of the ten-eleven translocation (TET) enzymes. In DNA methylation, TETs are responsible for balancing the hydroxymethylated cytosines (5hmC) to favor gene expression. The therapeutic potential of demethylation will also be explored to correct the epigenetic profile and restore the disrupted gene expression.

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Net EU contribution
€ 196 707,84
Address
Rue De Tolbiac 101
75654 Paris
France

See on map

Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Other funding
€ 0,00